Fig. 1 · Structure
Documents & Downloads
VV261
Antiviral Inhibitor
VV261 is an orally active prodrug of 4'-fluorouridine that targets viral RNA-dependent RNA polymerase, effectively inhibiting its activity. This compound demonstrates antiviral efficacy against various viruses, including Crimean-Congo hemorrhagic fever virus (CCHFV), severe fever with thrombocytopenia syndrome virus (SFTSV), and lymphocytic choriomeningitis virus (LCMV). VV261 is valuable for research applications focused on understanding viral infections and developing antiviral therapies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 3003864-86-3 |
| Applications | Antiviral Inhibitor |
| Formula | C28H34FN3O11 |
| Molecular Weight | 607.58 |
| SMILES | O=C(C1=CC=CN=C1)OCN2C(N(C=CC2=O)[C@@H]3O[C@@](COC(C(C)C)=O)(F)[C@@H](OC(C(C)C)=O)[C@H]3OC(C(C)C)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.